Literature DB >> 19778357

PTH-independent hypercalcaemia and non-melanoma skin cancer.

I Nicolae1, S Schipor.   

Abstract

BACKGROUND: Recently, it became more evident that skin is a target for neuroendocrine signals. AIMS: (1) To evaluate the relationship between tumour aggressiveness and hypercalcaemia in patients with non-melanoma skin cancer; (2) to identify clinical, functional, biological alterations caused by this setting; (3) calcium redistribution from extracellular fluids to intracellular compartments; (4) to describe several molecular aspects of hypercalcaemia development.
MATERIALS AND METHODS: This study was conducted between January 2000 and May 2009 in Dermatoveneorological Center, Bucharest. From the 1232 cases that were investigated, there were 32 patients with keratoachantoma, 468 patients with basal cell carcinoma, 412 patients with squamous cell carcinoma and 320 healthy volunteers. All the patients were screened by clinical and paraclinical examinations (haematology, biochemistry, immunology). After biochemical confirmation of hypercalcaemia, patients had endocrine tests, electrocardiography and imagistic approaches. Total serum calcium was measured in extracellular fluids (serum, urine) by spectrophotometric methods. Ionized calcium was calculated depending on total serum calcium and total proteins. Corrected serum total calcium (cTCa) levels were calculated using albumin and total serum calcium levels. In tumour tissues and intact skin, calcium was assayed by physical methods of analysis: Instrumental Neutron Activation Analysis (INAA), Proton-Induced X-ray Emission (PIXE). Intact PTH was measured by ELISA.
RESULTS: PTH-independent hypercalcaemia prevalence is low in SCC patients (1.21%). Hypercalcaemia manifestations are multiple including: digestive, renal, neuromuscular, and cardiovascular abnormalities. In these patients, intact PTH (iPTH) is normal, urinary calcium is decreased, serum albumin is reduced, and calcium concentration in tumour tissue is significantly increased compared to healthy tissue.
CONCLUSIONS: PTH-independent hypercalcaemia has a low prevalence in SCC patients. Hypercalcaemia is correlated with susceptibility to develop metastases in SCC. A possible mechanism is PTHrp hypersecretion by malignant keratinocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19778357     DOI: 10.1111/j.1468-3083.2009.03441.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  4 in total

1.  Bone metastases and hypercalcaemia from cutaneous squamous cell carcinoma.

Authors:  Panagiotis J Vlachostergios; Rajeev L Balmiki
Journal:  BMJ Case Rep       Date:  2014-06-09

2.  Successful treatment of paraneoplastic hypercalcemia in a patient with giant condyloma acuminatum: a case report.

Authors:  Thomas Linnemann; Frauke Müller; Mathias Löhnert; Peter Hirnle; Martin Görner
Journal:  J Med Case Rep       Date:  2013-11-07

Review 3.  Paraneoplastic Syndromes in Patients with Keratinocyte Skin Cancer.

Authors:  Christoforos Vlachos; Chrysanthi Tziortzioti; Ioannis D Bassukas
Journal:  Cancers (Basel)       Date:  2022-01-04       Impact factor: 6.639

4.  A Male Patient with Humoral Hypercalcemia of Malignancy (HHM) with Leukocytosis Caused by Cutaneous Squamous Cell Carcinoma Resulting from Recessive Dystrophic Epidermolysis Bullosa.

Authors:  Kohji Miura; Noriko Umegaki; Taichi Kitaoka; Takuo Kubota; Noriyuki Namba; Yuri Etani; Haruhiko Hirai; Shigetoyo Kogaki; Shigeo Nakajima; Yuji Takahashi; Katsuto Tamai; Ichiro Katayama; Keiichi Ozono
Journal:  Clin Pediatr Endocrinol       Date:  2011-10-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.